Mastercard rarely goes on sale and is now a world-class compounder at one of its least demanding valuations in years. It trades at 21.8x EV/EBIT, barely above its lowest valuation since 2018 and less than half its 2021 peak multiple. x.com  x.com 

Mastercard may be the only scaled, capital-light network benefiting from AI, with bloated technical debt uniquely addressable by coding tools. Nominal inflation-linked recurring revenues and hardware attach add to the case at low-teens free-cash-flow yields. While payments getting bid in a red market probably signals the rally is over, these traits could mean it is not. x.com 

Mastercard is worth about $473 per share on 13% growth in years one to five, with a conservative case of $342 and an optimistic case of $596. The wide range depends on whether near-term growth in payment volumes holds. x.com 

American Express's credit risk keeps its multiple below Visa's or Mastercard's, but that persistently low valuation lets management retire shares steadily. At 16x forward earnings it is not especially cheap by its own history; 28% of shares were retired over ten years. Buying here looks more like owning a steady cash-returning compounder than expecting extraordinary returns. x.com 

The Mastercard and Visa payment duopoly is currently on sale. x.com 

Mastercard isn't really cheap for its growth, while Nvidia is cheap, and Nvidia should handily outperform Mastercard over the next three years. x.com 

Visa and Mastercard look like attractive, safe cash machines at decade-low valuations, likely compounding 10-15% a year from here. Mastercard trades at 23x forward earnings, its lowest in a decade, and Visa at 22x; Mastercard just bounced off its 200-week moving average, untouched since 2022. They will not 10x in ten years but should protect the downside. Visa is slightly preferred for its sheer size, though Mastercard grows faster. x.com 

Mastercard is undervalued, with a margin of safety above 15% below a $479 share price per a full valuation model. Its duopoly moat is solidly in place, and the company is not going anywhere. x.com 

S&P Global, Mastercard, Visa, Moody's and Berkshire Hathaway have turned from portfolio ballast into funding shorts. These EPS compounders once pulled portfolios up alongside spicier longs, but they are never particularly cheap, Visa may rise only 4-5% on great earnings, and they can't be taken out. For most investors' horizons they are irrelevant next to momentum stocks that gap up 30% on narratives, so owning them now means being long funding shorts. That could change. x.com  x.com 

American Express's continued growth makes its lower forward multiple than Mastercard and Visa a very attractive long-term opportunity. It trades at 16.7x forward earnings against more than 26x for each peer. All three sold off earlier this year, but Mastercard and Visa reached new highs while American Express remains down 15.6% year to date. x.com